869 related articles for article (PubMed ID: 18352997)
1. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
Flapper BC; Schoemaker MM
Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
[TBL] [Abstract][Full Text] [Related]
2. Fine motor skills and effects of methylphenidate in children with attention-deficit-hyperactivity disorder and developmental coordination disorder.
Flapper BC; Houwen S; Schoemaker MM
Dev Med Child Neurol; 2006 Mar; 48(3):165-9. PubMed ID: 16483390
[TBL] [Abstract][Full Text] [Related]
3. A preliminary study on the effect of methylphenidate on motor performance in children with comorbid DCD and ADHD.
Bart O; Podoly T; Bar-Haim Y
Res Dev Disabil; 2010; 31(6):1443-7. PubMed ID: 20650602
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
5. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
[TBL] [Abstract][Full Text] [Related]
6. Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system.
Yoo HK; Park S; Wang HR; Lee JS; Kim K; Paik KW; Yum MS; Ko TS
Epileptic Disord; 2009 Dec; 11(4):301-8. PubMed ID: 20007067
[TBL] [Abstract][Full Text] [Related]
7. Exploring the impact of once-daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPH.
Kordon A; Stollhoff K; Niederkirchner K; Mattejat F; Rettig K; Schäuble B
Postgrad Med; 2011 Sep; 123(5):27-38. PubMed ID: 21904084
[TBL] [Abstract][Full Text] [Related]
8. Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.
Niederkirchner K; Slawik L; Wermelskirchen D; Rettig K; Schäuble B
Expert Rev Neurother; 2011 Apr; 11(4):499-508. PubMed ID: 21469923
[TBL] [Abstract][Full Text] [Related]
9. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
[TBL] [Abstract][Full Text] [Related]
10. Influence of methylphenidate on motor performance and attention in children with developmental coordination disorder and attention deficit hyperactive disorder.
Bart O; Daniel L; Dan O; Bar-Haim Y
Res Dev Disabil; 2013 Jun; 34(6):1922-7. PubMed ID: 23584172
[TBL] [Abstract][Full Text] [Related]
11. Motor skills of children newly diagnosed with Attention Deficit Hyperactivity Disorder prior to and following treatment with stimulant medication.
Brossard-Racine M; Shevell M; Snider L; Bélanger SA; Majnemer A
Res Dev Disabil; 2012; 33(6):2080-7. PubMed ID: 22796639
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
Levin FR; Evans SM; Brooks DJ; Garawi F
Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
[TBL] [Abstract][Full Text] [Related]
13. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
Fallu A; Richard C; Prinzo R; Binder C
Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
[TBL] [Abstract][Full Text] [Related]
14. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
15. Depression, anxiety and obsessive-compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment.
Gürkan K; Bilgiç A; Türkoglu S; Kiliç BG; Aysev A; Uslu R
J Psychopharmacol; 2010 Dec; 24(12):1810-8. PubMed ID: 19939861
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
17. Developmental coordination disorder in children with attention-deficit-hyperactivity disorder and physical therapy intervention.
Watemberg N; Waiserberg N; Zuk L; Lerman-Sagie T
Dev Med Child Neurol; 2007 Dec; 49(12):920-5. PubMed ID: 18039239
[TBL] [Abstract][Full Text] [Related]
18. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
19. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder.
Bukstein OG; Kolko DJ
J Clin Child Psychol; 1998 Oct; 27(3):340-51. PubMed ID: 9789193
[TBL] [Abstract][Full Text] [Related]
20. Actigraphic monitoring during sleep of children with ADHD on methylphenidate and placebo.
Schwartz G; Amor LB; Grizenko N; Lageix P; Baron C; Boivin DB; Joober R
J Am Acad Child Adolesc Psychiatry; 2004 Oct; 43(10):1276-82. PubMed ID: 15381895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]